CCM
TLSI icon

Connective Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Connective Capital Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,796
Closed -$229K – 85
2025
Q4 		$229K Hold
32,796
– – 0.13% 40
2025
Q3 		$153K Hold
32,796
– – 0.14% 62
2025
Q2 		$179K Buy
32,796
+3,717
+13% +$19.9K 0.17% 42
2025
Q1 		$161K Buy
29,079
+1,090
+4% +$5.8K 0.15% 39
2024
Q4 		$140K Buy
+27,989
New +$118K 0.16% 53

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Connective Capital Management's TLSI Position: Q1 2026 in Review

Connective Capital Management sold out of TriSalus Life Sciences (TLSI) in Q1 2026, closing a stake of 32,796 shares — an estimated $229K sold.

Connective Capital Management first reported a position in TLSI in Q4 2024 and held it in 5 quarters. The position peaked at $229K in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Connective Capital Management reported no remaining TriSalus Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Connective Capital Management sold 32,796 TriSalus Life Sciences shares in Q1 2026, an estimated $229K.
  • Connective Capital Management first reported a position in TriSalus Life Sciences in Q4 2024 and held it in 5 quarters.
  • Connective Capital Management's TriSalus Life Sciences position peaked at $229K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Connective Capital Management's 13F filing for Q1 2026, filed 13 May 2026.